- Home
- BMRN vs SOLV Comparison
BMRN vs SOLV Comparison
Compare BMRN & SOLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- SOLV
- Stock Information
- Founded
- BMRN 1996
- SOLV 2023
- Country
- BMRN United States
- SOLV United States
- Employees
- BMRN N/A
- SOLV N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- SOLV
- Sector
- BMRN Health Care
- SOLV
- Exchange
- BMRN Nasdaq
- SOLV NYSE
- Market Cap
- BMRN 13.7B
- SOLV 12.6B
- IPO Year
- BMRN 1999
- SOLV N/A
- Fundamental
- Price
- BMRN $71.44
- SOLV $74.74
- Analyst Decision
- BMRN Buy
- SOLV Hold
- Analyst Count
- BMRN 22
- SOLV 10
- Target Price
- BMRN $94.00
- SOLV $79.86
- AVG Volume (30 Days)
- BMRN 1.5M
- SOLV 1.2M
- Earning Date
- BMRN 04-23-2025
- SOLV 04-07-2025
- Dividend Yield
- BMRN N/A
- SOLV N/A
- EPS Growth
- BMRN 153.71
- SOLV N/A
- EPS
- BMRN 2.21
- SOLV 2.76
- Revenue
- BMRN $2,853,915,000.00
- SOLV $8,254,000,000.00
- Revenue This Year
- BMRN $12.23
- SOLV $2.35
- Revenue Next Year
- BMRN $9.90
- SOLV $1.67
- P/E Ratio
- BMRN $32.37
- SOLV $27.08
- Revenue Growth
- BMRN 17.97
- SOLV 0.69
- 52 Week Low
- BMRN $60.63
- SOLV $47.16
- 52 Week High
- BMRN $94.85
- SOLV $85.92
- Technical
- Relative Strength Index (RSI)
- BMRN 55.89
- SOLV N/A
- Support Level
- BMRN $69.60
- SOLV N/A
- Resistance Level
- BMRN $73.18
- SOLV N/A
- Average True Range (ATR)
- BMRN 1.64
- SOLV 0.00
- MACD
- BMRN -0.15
- SOLV 0.00
- Stochastic Oscillator
- BMRN 63.45
- SOLV 0.00
Stock Price Comparison Chart: BMRN vs SOLV
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About SOLV SOLVENTUM CORP
Solventum Corp is an independent healthcare company with a primary focus on addressing healthcare challenges. Its diverse product portfolio spans the healthcare industry, including medical solutions, oral care, health information systems, and separation and purification sciences.